Compare Exelon Corporation Common Stock (EXC) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelon Corporation Common Stock vs Immunovant Inc. Common Stock — how do they compare? Exelon Corporation Common Stock trades at $41.74 (market cap $42.75B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Exelon Corporation Common Stock is far larger — about 6.5× Immunovant Inc. Common Stock's market cap, and Exelon Corporation Common Stock pays a 4.05% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXC | IMVT | |
|---|---|---|
Market Cap | $42.75B | $6.62B |
Volume | 7,084,069 | 1,131,364 |
Sector | Utilities | Health |
52-Week High | $50.29 | $44.96 |
52-Week Low | $40.20 | $17.03 |
Enterprise Value | $93.61B | $5.72B |
Dividend Yield | 4.05% | — |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
